Stock Analysis
- United States
- /
- Healthcare Services
- /
- NasdaqCM:SYRA
Syra Health Third Quarter 2024 Earnings: US$0.057 loss per share (vs US$0.081 loss in 3Q 2023)
Syra Health (NASDAQ:SYRA) Third Quarter 2024 Results
Key Financial Results
- Revenue: US$2.25m (up 43% from 3Q 2023).
- Net loss: US$417.5k (loss widened by 18% from 3Q 2023).
- US$0.057 loss per share.
All figures shown in the chart above are for the trailing 12 month (TTM) period
Syra Health shares are up 14% from a week ago.
Risk Analysis
Be aware that Syra Health is showing 5 warning signs in our investment analysis and 4 of those can't be ignored...
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NasdaqCM:SYRA
Syra Health
A healthcare services company, provides solutions in behavioral and mental health, population health, digital health, health education, and healthcare workforce in the United States.